BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32547689)

  • 1. Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population.
    Pham TTT; Ho DT; Nguyen T
    World J Hepatol; 2020 May; 12(5):220-229. PubMed ID: 32547689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
    Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
    Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
    Vincent JP; Ndow G; Ogawa S; Ceesay A; Njie R; Sanneh B; Baldeh I; D'Alessandro U; Mendy M; Thursz M; Chemin I; Tanaka Y; Lemoine M; Shimakawa Y
    J Glob Health; 2022 Nov; 12():04076. PubMed ID: 36370422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection.
    Ueda N; Kawaoka T; Imamura M; Aikata H; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Hayes CN; Yokozaki M; Chayama K
    BMC Gastroenterol; 2020 Sep; 20(1):314. PubMed ID: 32977741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
    Nah EH; Cho S; Kim S; Kim HS; Cho HI
    J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
    Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
    Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.
    Moon HW; Park M; Hur M; Kim H; Choe WH; Yun YM
    Ann Lab Med; 2018 Jul; 38(4):331-337. PubMed ID: 29611383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Change in Serum Levels of New Hepatic Fibrosis Marker "Mac-2 Binding Protein Glycosylation isomer (M2BPGi)" in Patients with Chronic Hepatitis C during the Treatment of Pegylated Interferon and Ribavirin].
    Ishida H; Suetsugu A; Nakamura M; Tauchi R; Nakayama J; Katano Y; Shirakami Y; Furuta N; Ito H; Seishima M
    Rinsho Byori; 2015 Aug; 63(8):901-6. PubMed ID: 26638424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
    Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
    J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection.
    Liu CH; Liu CJ; Su TH; Huang SC; Tseng TC; Wu JH; Chen PJ; Kao JH
    Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease.
    Tangvoraphonkchai K; Suttichaimongkol T; Kularbkaew C; Sangaimwibool P; Sukeepaisarnjaroen W
    Sci Rep; 2022 Apr; 12(1):6757. PubMed ID: 35474106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
    J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer.
    Hur M; Park M; Moon HW; Choe WH; Lee CH
    Ann Lab Med; 2022 Mar; 42(2):249-257. PubMed ID: 34635616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver fibrosis improvement assessed by magnetic resonance elastography and Mac-2-binding protein glycosylation isomer in patients with hepatitis C virus infection receiving direct-acting antivirals.
    Chuaypen N; Chittmittrapap S; Avihingsanon A; Siripongsakun S; Wongpiyabovorn J; Tanpowpong N; Tanaka Y; Tangkijvanich P
    Hepatol Res; 2021 May; 51(5):528-537. PubMed ID: 33615687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
    Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
    Clin Transl Gastroenterol; 2018 Jun; 9(6):163. PubMed ID: 29915243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection.
    Jun T; Hsu YC; Ogawa S; Huang YT; Yeh ML; Tseng CH; Huang CF; Tai CM; Dai CY; Huang JF; Chuang WL; Yu ML; Tanaka Y; Nguyen MH
    Hepatol Commun; 2019 Apr; 3(4):493-503. PubMed ID: 30976740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).
    Ueno T; Takase K; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2022 Dec; 38(12):1807-1813. PubMed ID: 36125546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Mac-2 Binding Protein Glycosylation Isomer to Evaluate Graft Status After Liver Transplantation.
    Kimura Y; Taura K; Hai Nam N; Uemoto Y; Yoshino K; Ikeno Y; Okuda Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Anazawa T; Fukumitsu K; Ito T; Yagi S; Kamo N; Seo S; Iwaisako K; Hata K; Imai T; Uemoto S
    Liver Transpl; 2021 Feb; 27(3):403-415. PubMed ID: 32780942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma.
    Okuda Y; Taura K; Yoshino K; Ikeno Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Hatano E; Tanaka S; Uemoto S
    Ann Surg; 2017 Jun; 265(6):1201-1208. PubMed ID: 27355265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.